Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802111

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802111

Global Respiratory Care Devices Market Size study & Forecast, by Product, by Disease Indication, by End User and Regional Forecasts 2025-2035

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Respiratory Care Devices Market is valued at approximately USD 21.99 billion in 2024 and is anticipated to expand at a CAGR of 7.30% over the forecast period of 2025-2035. Respiratory care devices are critical medical equipment designed to support patients with acute and chronic respiratory disorders, enhancing oxygen delivery, monitoring lung function, and improving overall patient outcomes. These devices play a pivotal role in treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections while also providing life-saving support in intensive care units. The global market growth is underpinned by rising cases of respiratory illnesses, accelerated urban pollution levels, increasing adoption of home-based healthcare, and the expanding geriatric population susceptible to respiratory complications. Furthermore, advancements in portable respiratory technology and telehealth integration continue to shape the demand landscape positively.

The surge in infectious disease prevalence, particularly respiratory infections such as influenza, tuberculosis, and COVID-19, has dramatically amplified the demand for respiratory care devices across healthcare systems worldwide. The accelerated consumption of ventilators and oxygen concentrators during pandemic peaks has highlighted the critical role these devices play in life-support management. According to WHO, nearly 262 million people are affected by asthma globally, while COPD remains one of the leading causes of mortality worldwide. The rising burden of such diseases, coupled with lifestyle shifts, smoking prevalence, and occupational hazards, is propelling the adoption of respiratory care equipment. Meanwhile, technological progress in non-invasive ventilation, portable oxygen delivery systems, and AI-enabled respiratory monitoring has opened lucrative growth opportunities for manufacturers. However, cost barriers in low- and middle-income countries and a growing tilt toward preventive over therapeutic care pose challenges to sustained expansion.

The detailed segments and sub-segments included in the report are:

By Product:

  • PAP Devices
  • Ventilators
  • Humidifiers
  • Oxygen Concentrators
  • Spirometers
  • Peak Flow Meter
  • Masks

By Disease Indication:

  • Asthma
  • Infectious Disease

By End User:

  • Hospitals
  • Homecare Settings

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
  • Hospitals are Expected to Dominate the Market
  • Hospitals continue to represent the dominant end-user segment, accounting for the majority of respiratory care device usage. The growing demand for advanced ventilation systems in intensive care units, coupled with hospital-led adoption of modern respiratory diagnostics, underpins their market leadership. Hospitals benefit from established procurement channels and access to state-of-the-art respiratory support technologies, ensuring rapid adoption. Although hospitals hold the lion's share, the homecare setting is emerging as a promising frontier, driven by a rising preference for home-based treatment solutions, cost-effectiveness, and greater convenience for patients managing chronic conditions. This dual dynamic reflects both the entrenched hospital dominance and the rising attractiveness of decentralized care.
  • Ventilators Lead in Revenue Contribution
  • Among product categories, ventilators contribute the highest revenue, supported by their indispensable role in critical and emergency care management. Their extensive deployment during global health crises further reinforced their indispensable value within intensive care settings. Simultaneously, oxygen concentrators and PAP devices are gaining prominence, largely due to their utility in homecare environments and chronic disease management. This indicates a market bifurcation: ventilators remain the backbone of revenue streams within acute care, whereas portable oxygen systems and PAP devices accelerate growth prospects in home settings. The current outlook paints ventilators as dominant revenue generators, while next-generation portable devices are steadily carving out rising market share.
  • The key regions considered for the Global Respiratory Care Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America commanded the market in 2025, bolstered by its advanced healthcare infrastructure, high incidence of respiratory diseases, widespread insurance coverage, and rapid integration of innovative respiratory technologies. Meanwhile, Asia Pacific is poised to be the fastest-growing market, fueled by soaring pollution levels, increasing tobacco consumption, urbanization-driven disease prevalence, and government-backed investments in healthcare modernization. Countries such as China and India stand at the forefront of this surge, where an expanding patient pool and improved affordability are converging to accelerate adoption. Europe follows closely, benefiting from robust healthcare systems and a growing elderly population requiring respiratory support.

Major market players included in this report are:

  • Philips Healthcare
  • ResMed Inc.
  • Medtronic plc
  • Dragerwerk AG & Co. KGaA
  • Hamilton Medical AG
  • Fisher & Paykel Healthcare Corporation Limited
  • Vyaire Medical, Inc.
  • GE Healthcare
  • Smiths Medical (ICU Medical Inc.)
  • Masimo Corporation
  • Nihon Kohden Corporation
  • Becton, Dickinson and Company
  • 3M Healthcare
  • Honeywell International Inc.
  • Mindray Medical International Limited

Global Respiratory Care Devices Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of the competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Respiratory Care Devices Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Respiratory Care Devices Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Respiratory Care Devices Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Rising cases of respiratory illnesses, accelerated urban pollution levels
    • 3.2.2. increasing adoption of home-based healthcare
  • 3.3. Restraints
    • 3.3.1. Cost barriers in low- and middle-income countries
    • 3.3.2. Growing tilt toward preventive over therapeutic care
  • 3.4. Opportunities
    • 3.4.1. Rising burden of such diseases, coupled with lifestyle shifts, smoking prevalence, and occupational hazards

Chapter 4. Global Spacer Fluid Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Respiratory Care Devices Market Size & Forecasts by Product 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 5.3. PAP Devices
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Ventilators
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035
  • 5.5. Humidifiers
    • 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.5.2. Market size analysis, by region, 2025-2035
  • 5.6. Oxygen Concentrators
    • 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.6.2. Market size analysis, by region, 2025-2035
  • 5.7. Spirometers
    • 5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.7.2. Market size analysis, by region, 2025-2035
  • 5.8. Peak Flow Meter
    • 5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.8.2. Market size analysis, by region, 2025-2035
  • 5.9. Masks
    • 5.9.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.9.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Respiratory Care Devices Market Size & Forecasts by Disease Indication 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 6.3. Asthma
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Infectious DIsease
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Respiratory Care Devices Market Size & Forecasts by End User 2025-2035

  • 7.1. Market Overview
  • 7.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 7.3. Hospitals
    • 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 7.3.2. Market size analysis, by region, 2025-2035
  • 7.4. Homecare Settings
    • 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 7.4.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Respiratory Care Devices Market Size & Forecasts by Region 2025-2035

  • 8.1. Growth Respiratory Care Devices Market, Regional Market Snapshot
  • 8.2. Top Leading & Emerging Countries
  • 8.3. North America Respiratory Care Devices Market
    • 8.3.1. U.S. Respiratory Care Devices Market
      • 8.3.1.1. Product breakdown size & forecasts, 2025-2035
      • 8.3.1.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.3.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.3.2. Canada Respiratory Care Devices Market
      • 8.3.2.1. Product breakdown size & forecasts, 2025-2035
      • 8.3.2.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.3.2.3. End User breakdown size & forecasts, 2025-2035
  • 8.4. Europe Respiratory Care Devices Market
    • 8.4.1. UK Respiratory Care Devices Market
      • 8.4.1.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.1.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.2. Germany Respiratory Care Devices Market
      • 8.4.2.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.2.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.3. France Respiratory Care Devices Market
      • 8.4.3.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.3.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.3.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.4. Spain Respiratory Care Devices Market
      • 8.4.4.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.4.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.4.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.5. Italy Respiratory Care Devices Market
      • 8.4.5.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.5.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.5.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.6. Rest of Europe Respiratory Care Devices Market
      • 8.4.6.1. Product breakdown size & forecasts, 2025-2035
      • 8.4.6.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.4.6.3. End User breakdown size & forecasts, 2025-2035
  • 8.5. Asia Pacific Respiratory Care Devices Market
    • 8.5.1. China Respiratory Care Devices Market
      • 8.5.1.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.1.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.2. India Respiratory Care Devices Market
      • 8.5.2.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.2.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.3. Japan Respiratory Care Devices Market
      • 8.5.3.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.3.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.3.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.4. Australia Respiratory Care Devices Market
      • 8.5.4.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.4.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.4.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.5. South Korea Respiratory Care Devices Market
      • 8.5.5.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.5.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.5.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.6. Rest of APAC Respiratory Care Devices Market
      • 8.5.6.1. Product breakdown size & forecasts, 2025-2035
      • 8.5.6.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.5.6.3. End User breakdown size & forecasts, 2025-2035
  • 8.6. Latin America Respiratory Care Devices Market
    • 8.6.1. Brazil Respiratory Care Devices Market
      • 8.6.1.1. Product breakdown size & forecasts, 2025-2035
      • 8.6.1.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.6.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.6.2. Mexico Respiratory Care Devices Market
      • 8.6.2.1. Product breakdown size & forecasts, 2025-2035
      • 8.6.2.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.6.2.3. End User breakdown size & forecasts, 2025-2035
  • 8.7. Middle East and Africa Respiratory Care Devices Market
    • 8.7.1. UAE Respiratory Care Devices Market
      • 8.7.1.1. Product breakdown size & forecasts, 2025-2035
      • 8.7.1.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.7.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.7.2. Saudi Arabia (KSA) Respiratory Care Devices Market
      • 8.7.2.1. Product breakdown size & forecasts, 2025-2035
      • 8.7.2.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.7.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.7.3. South Africa Respiratory Care Devices Market
      • 8.7.3.1. Product breakdown size & forecasts, 2025-2035
      • 8.7.3.2. Disease Indication breakdown size & forecasts, 2025-2035
      • 8.7.3.3. End User breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Philips Healthcare
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Financial Performance (Subject to Data Availability)
    • 9.2.5. Product/Services Port
    • 9.2.6. Recent Development
    • 9.2.7. Market Strategies
    • 9.2.8. SWOT Analysis
  • 9.3. ResMed Inc.
  • 9.4. Medtronic plc
  • 9.5. Dragerwerk AG & Co. KGaA
  • 9.6. Hamilton Medical AG
  • 9.7. Fisher & Paykel Healthcare Corporation Limited
  • 9.8. Vyaire Medical, Inc.
  • 9.9. GE Healthcare
  • 9.10. Smiths Medical (ICU Medical Inc.)
  • 9.11. Masimo Corporation
  • 9.12. Nihon Kohden Corporation
  • 9.13. Becton, Dickinson and Company
  • 9.14. 3M Healthcare
  • 9.15. Honeywell International Inc.
  • 9.16. Mindray Medical International Limited
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!